369 related articles for article (PubMed ID: 28693519)
41. UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV: Incidence of Blindness and Sight Impairment in Ranibizumab-Treated Patients.
Johnston RL; Lee AY; Buckle M; Antcliff R; Bailey C; McKibbin M; Chakravarthy U; Tufail A;
Ophthalmology; 2016 Nov; 123(11):2386-2392. PubMed ID: 27615601
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes.
Ozkaya A; Alkin Z; Osmanbasoglu OA; Ozkaya HM; Demirok A
J Fr Ophtalmol; 2014 Apr; 37(4):280-7. PubMed ID: 24657215
[TBL] [Abstract][Full Text] [Related]
43. Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study.
Gillies MC; Nguyen V; Daien V; Arnold JJ; Morlet N; Barthelmes D
Ophthalmology; 2016 Dec; 123(12):2545-2553. PubMed ID: 27707549
[TBL] [Abstract][Full Text] [Related]
44. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.
Mruthyunjaya P; Stinnett SS; Toth CA
Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328
[TBL] [Abstract][Full Text] [Related]
45. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration.
Rasmussen A; Brandi S; Fuchs J; Hansen LH; Lund-Andersen H; Sander B; Larsen M
Acta Ophthalmol; 2015 Nov; 93(7):616-20. PubMed ID: 26073051
[TBL] [Abstract][Full Text] [Related]
46. Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.
Mimura K; Matsumoto H; Morimoto M; Akiyama H
Ophthalmologica; 2018; 239(2-3):121-127. PubMed ID: 29169154
[TBL] [Abstract][Full Text] [Related]
47. Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany.
Finger RP; Wiedemann P; Blumhagen F; Pohl K; Holz FG
Acta Ophthalmol; 2013 Sep; 91(6):540-6. PubMed ID: 23171290
[TBL] [Abstract][Full Text] [Related]
48. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.
Ba J; Peng RS; Xu D; Li YH; Shi H; Wang Q; Yu J
Drug Des Devel Ther; 2015; 9():5397-405. PubMed ID: 26451092
[TBL] [Abstract][Full Text] [Related]
49. Choroidal thickness and visual prognosis in type 1 lesion due to neovascular age-related macular degeneration.
Hernández-Martínez P; Dolz-Marco R; Hervás-Marín D; Andreu-Fenoll M; Gallego-Pinazo R; Arévalo JF
Eur J Ophthalmol; 2017 Mar; 27(2):196-200. PubMed ID: 27646337
[TBL] [Abstract][Full Text] [Related]
50. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11.
Hawkins BS; Bressler NM; Miskala PH; Bressler SB; Holekamp NM; Marsh MJ; Redford M; Schwartz SD; Sternberg P; Thomas MA; Wilson DJ;
Ophthalmology; 2004 Nov; 111(11):1967-80. PubMed ID: 15522362
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age-related macular degeneration in a well-defined region of the United Kingdom.
Buckle M; Lee A; Mohamed Q; Fletcher E; Sallam A; Healy R; Stratton I; Tufail A; Johnston RL
Eye (Lond); 2015 Mar; 29(3):403-8. PubMed ID: 25592123
[TBL] [Abstract][Full Text] [Related]
52. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.
Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH
Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749
[TBL] [Abstract][Full Text] [Related]
53. Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience.
Ozkaya A; Alkin Z; Togac M; Ahmet S; Perente I; Taskapili M
Korean J Ophthalmol; 2017 Oct; 31(5):424-430. PubMed ID: 28913999
[TBL] [Abstract][Full Text] [Related]
54. [Transpupillary thermotherapy in exsudative age-related macular degeneration. Two-years results and findings on the other eye].
Karel I; Záhlava J; Boguszaková J; Dubská Z; Lestiák J
Cesk Slov Oftalmol; 2005 May; 61(3):154-65. PubMed ID: 15981488
[TBL] [Abstract][Full Text] [Related]
55. NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS.
Kim JH; Chang YS; Kim JW
Retina; 2017 Dec; 37(12):2254-2261. PubMed ID: 28092343
[TBL] [Abstract][Full Text] [Related]
56. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
Frennesson C; Nilsson UL; Peebo BB; Nilsson SE
Acta Ophthalmol; 2010 Jun; 88(4):420-5. PubMed ID: 19678811
[TBL] [Abstract][Full Text] [Related]
57. Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration.
Essex RW; Tufail A; Bunce C; Aylward GW
Br J Ophthalmol; 2007 May; 91(5):649-54. PubMed ID: 17446505
[TBL] [Abstract][Full Text] [Related]
58. Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration.
Essex RW; Nguyen V; Walton R; Arnold JJ; McAllister IL; Guymer RH; Morlet N; Young S; Barthelmes D; Gillies MC;
Ophthalmology; 2016 Nov; 123(11):2393-2400. PubMed ID: 27554034
[TBL] [Abstract][Full Text] [Related]
59. Functional impact of treatment with ranibizumab under a reactive strategy in patients with neovascular age-related macular degeneration.
Gallego-Pinazo R; Dolz-Marco R; Andreu-Fenoll M; Farrés J; Monclús L
Arch Soc Esp Oftalmol; 2017 Mar; 92(3):120-127. PubMed ID: 27751585
[TBL] [Abstract][Full Text] [Related]
60. Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration.
Bonnin P; Pournaras JA; Lazrak Z; Cohen SY; Legargasson JF; Gaudric A; Levy BI; Massin P
Acta Ophthalmol; 2010 Sep; 88(6):641-5. PubMed ID: 19563370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
